treatment
pulmonary
infection
patient
cystic
fibrosis
comparative
study
ticarcillin
gentamicin
effectiveness
ticarcillin
pseudomonas
aeruginosa
acute
exacerbation
pulmonary
infection
patient
cystic
fibrosis
evaluated
seventy
one
percent
patient
treated
ticarcillin
alone
responded
favorably
response
rate
similar
patient
treated
combination
ticarcillin
plus
gentamicin
gentamicin
alone
severity
underlying
disease
important
determinant
response
treatment
ticarcillin
resistant
organism
recovered
treatment
patient
received
drug
recovery
prevented
inclusion
gentamicin
therapeutic
regimen
interfere
clinical
improvement
ticarcillin
resistant
strain
persisted
follow
two
six
month
completion
therapy
one
ten
patient
serious
toxicity
ticarcillin
noted
study
period
